Order Article Reprints

O’Regan S, O’Kelly B, Reidy P, O’Toole A, Caird J, McNally C, McConkey S, De Barra E. Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis. Journal of Fungi. 2022; 8(6):557. https://doi.org/10.3390/jof8060557

O’Regan, Siobhan, Brendan O’Kelly, Paul Reidy, Aoibhlinn O’Toole, John Caird, Cora McNally, Samuel McConkey, and Eoghan De Barra. 2022. "Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis" Journal of Fungi 8, no. 6: 557. https://doi.org/10.3390/jof8060557

O’Regan, S., O’Kelly, B., Reidy, P., O’Toole, A., Caird, J., McNally, C., McConkey, S., & De Barra, E. (2022). Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis. Journal of Fungi, 8(6), 557. https://doi.org/10.3390/jof8060557